Directorio de personas
Judit Pallares Quixal

Judit Pallares Quixal

Grado: Doctor/a


jpallares.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/A-6635-2010

Publicaciones

  • Velasco A; Pallares J; Santacana M; Yeramian A; Dolcet X; Eritja N; Puente S; Sorolla A; Llecha N; Matias-Guiu X

    Loss of heterozygosity in endometrial carcinoma.

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 27 305-317. .

    [doi:10.1097/PGP.0b013e31815daf1a]

  • Pallares, Judit; Velasco, Ana; Eritja, Nuria; Santacana, Maria; Dolcet, Xavier; Cuatrecasas, Miriam; Palomar-Asenjo, Victor; Catasus, Lluis; Prat, Jaime; Matias-Guiu, Xavier

    Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma.

    Modern Pathology 21 691-699. .

    [doi:10.1038/modpathol.2008.38]

  • Llobet, D.; Eritja, N.; Encinas, M.; Llecha, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Gonzalez-Tallada, F. J.; Matias-Guiu, X.; Dolcet, X.

    CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.

    ONCOGENE 27 2513-2524. .

    [doi:10.1038/sj.onc.1210924]

  • Belen Madronero, Ana; Manuel Porcel, Jose; Bielsa, Silvia; Pallares, Judit

    Mitral endocarditis due to Escherichia coli

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 25 162-163. .

  • Velasco, Ana; Bussaglia, Elena; Pallares, Judit; Dolcet, Xavier; Llobet, David; Encinas, Mario; Llecha, Nuria; Palacios, Jose; Prat, Jaime; Matias-Guiu, Xavier

    PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

    HUMAN PATHOLOGY 37 1465-1472. .

    [doi:10.1016/j.humpath.2006.05.007]

  • Dolcet, Xavier; Llobet, David; Encinas, Mario; Pallares, Judit; Cabero, Albert; Schoenenberger, Joan Antoni; Comella, Joan X.; Matias-Guiu, Xavier

    Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants.

    Journal Of Biological Chemistry 281 22118-22130. .

    [doi:10.1074/jbc.M601350200]

  • Pallares, J; Rojo, F; Iriarte, J; Morote, J; Armadans, LI; De Torres, I

    Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues

    HISTOLOGY AND HISTOPATHOLOGY 21 857-865. .

  • Mayorga, ME; Sanchis, D; De Santos, AMP; Velasco, A; Dolcet, X; Casanova, JM; Baradad, M; Egido, R; Pallares, J; Espurz, N; Benitez, D; Mila, J; Malvehy, J; Castel, T; Comella, JX; Matias-Guiu, X; Vilella, R; Marti, RM

    Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines.

    MELANOMA RESEARCH 16 127-135. .

    [doi:10.1097/01.cmr.0000215039.30812.9b]

  • Nakamura, N; Carney, JA; Jin, L; Kajita, S; Pallares, J; Zhang, HY; Qian, X; Sebo, TJ; Erickson, LA; Lloyd, RV

    RaSSF1a and NORE1a methylation and BRaF(V600E) mutations in thyroid tumors

    LABORATORY INVESTIGATION 85 1065-1075. .

    [doi:10.1038/labinvest.3700306]

  • Dolcet, X; Llobet, D; Pallares, J; Rue, M; Comella, JX; Matias-Guiu, X

    FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis.

    LABORATORY INVESTIGATION 85 885-894. .

    [doi:10.1038/labinvest.3700286]

  • Pallares, J; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Palacios, J; Prat, J; Matias-Guiu, X

    Survivin expression in endometrial carcinoma - a tissue microarray study with correlation with PTEN and STaT-3

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 24 247-253. .

    [doi:10.1097/01.pgp.0000163849.37129.d4]

  • Pallares J; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Palacios J; Prat J; Matias-Guiu X

    Survivin expression in endometrial carcinoma: a tissue microarray study with correlation with PTEN and STAT-3.

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 24 247-253. .

Proyectos

  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
  • Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica
  • CARCINOMA DE ENDOMETRIO. VALORACION DELECCIONES Y AMPLIFICACIONES DE REGIONES CROMOSOMICAS MEDIANTE ARRAYS DE CGH
  • Alteraciones de la modulación de la vía RAS-MAPK y PI-3K en el cáncer de endometrio RASSF1A, NORE1A, Sprouty y PI3CA